July 20 (Reuters) - Eliem Therapeutics Inc ELYM.O :
* ELIEM THERAPEUTICS ANNOUNCES PLANS TO EXPLORE STRATEGIC
ALTERNATIVES
* ELIEM THERAPEUTICS INC - HAS MADE DETERMINATION TO HALT
FURTHER
DEVELOPMENT OF ITS KV7 PROGRAM
* ELIEM THERAPEUTICS INC - WILL EXPLORE POTENTIAL STRATEGIC
ALTERNATIVES THAT MAY INCLUDE, BUT ARE NOT LIMITED TO, AN
ACQUISITION, MERGER
* ELIEM THERAPEUTICS: AS OF JUNE 30, PRELIMINARY UNAUDITED
AMOUNT
OF ABOUT $102.6 MILLION IN CASH, CASH EQUIVALENTS AND
INVESTMENTS IN MARKETABLE SECURITIES
* ELIEM THERAPEUTICS INC - HAS ENGAGED LEERINK PARTNERS TO
ACT AS
A STRATEGIC ADVISOR IN PROCESS
Source text for Eikon: ID:nGNX1pMtyH
Further company coverage: ELYM.O
((Reuters.Briefs@thomsonreuters.com;))